4-氯-2,6-二[(2-羟基-3,5-二甲基-苯基)甲基]苯酚 | 6640-95-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二芳基庚烷
• 中文名称: 4-氯-2,6-二[(2-羟基-3,5-二甲基-苯基)甲基]苯酚
• 英文名称: 4-chloro-2,6-bis-(2-hydroxy-3,5-dimethyl-benzyl)-phenol
• 英文别名: 4-Chlor-2,6-bis-(2-hydroxy-3,5-dimethyl-benzyl)-phenol；2,2'-[(5-Chloro-2-hydroxy-1,3-phenylene)bis(methylene)]bis(4,6-dimethylphenol)；2-[[5-chloro-2-hydroxy-3-[(2-hydroxy-3,5-dimethylphenyl)methyl]phenyl]methyl]-4,6-dimethylphenol
• CAS: 6640-95-5
• 化学式: C₂₄H₂₅ClO₃
• 分子量: 396.914
• InChiKey: JQFAJTWMDXQZOR-UHFFFAOYSA-N

物化性质

• 熔点：
  170 °C
• 沸点：
  556.8±45.0 °C(Predicted)
• 密度：
  1.238±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  60.7
• 氢给体数：
  3
• 氢受体数：
  3

安全信息

• 海关编码：
  2908199090

反应信息

• 作为反应物：
  描述：

  4-氯-2,6-二[(2-羟基-3,5-二甲基-苯基)甲基]苯酚 在 镍 氢氧化钾 、 氢气 作用下， 以 甲醇 为溶剂， 生成 2-[[2-羟基-3-[(2-羟基-3,5-二甲基苯基)甲基]苯基]甲基]-4,6-二甲基苯酚
  参考文献：
  名称：

  Kinetik der Bromierung von Phenolen und phenolischen Mehrkernverbindungen, 5. Mitt.

  摘要：

  DOI：

  10.1007/bf00798422
• 作为产物：
  描述：

  5-氯间二甲苯-2,alpha,alpha'-三醇 、 2,4-二甲基苯酚 在 三氯氧磷 作用下， 生成 4-氯-2,6-二[(2-羟基-3,5-二甲基-苯基)甲基]苯酚
  参考文献：
  名称：

  Zigeuner; Elbel, Monatshefte fur Chemie, 1957, vol. 88, p. 622,628

  摘要：

  DOI：

文献信息

• Chemical entities that kill senescent cells for use in treating age-related disease
  申请人：Unity Biotechnology, Inc.

  公开号：US10195213B2

  公开（公告）日：2019-02-05

  Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.

  本文公开的化合物可有效治疗与衰老有关的各种疾病状态。所公开的化合物可用于消除衰老细胞以治疗疾病。化合物的给药方式包括单次给药和循环给药。
• GAIN-OF-FUNCTION BCL-2 INHIBITORS
  申请人：HOCKENBERY David

  公开号：US20120252839A1

  公开（公告）日：2012-10-04

  Compounds are described that are useful for treating an apoptosis-associated disease, which are specifically cytotoxic to tumor cells that are overexpressing Bcl-x L , and are much less cytotoxic in isogenic cells that are not overexpressing Bcl-x L . Also described is a method for treating an apoptosis-associated disease in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an active compound that is specifically cytotoxic to tumor cells that are overexpressing Bcl-x L , and are much less cytotoxic in isogenic cells that are not overexpressing Bcl-x L . Several scaffolds of active compounds are described.
• COMPOUNDS AND THERAPEUTIC USES
  申请人：Unity Biotechnology, Inc.

  公开号：US20170281649A1

  公开（公告）日：2017-10-05

  Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.
• US8865901B2
  申请人：——

  公开号：US8865901B2

  公开（公告）日：2014-10-21
• [EN] METHOD OF INHIBITING BCL-2-RELATED SURVIVAL PROTEINS<br/>[FR] PROCÉDÉ DESTINÉ À INHIBER DES PROTÉINES DE SURVIE APPARENTÉES AUX BCL-2
  申请人：HUTCHINSON FRED CANCER RES

  公开号：WO2011041731A2

  公开（公告）日：2011-04-07

  A method for treating an apoptosis-associated disease in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an active compound that is specifically cytotoxic to tumor cells that are overexpressing Bcl-xL, and are much less cytotoxic in isogenic cells that are not overexpressing Bcl-xL. Several scaffolds of active compounds are described.